Key result
Generic clopidogrel formulations require bioequivalence evaluation to ensure their established clinical usefulness in treating cardiovascular disease.
Key points are not available for this paper at this time.
Clinicians should verify bioequivalence before using generic clopidogrel in CVD; leaves open real-world outcome impacts without such data.
Clopidogrel is one of the most commonly prescribed antiplatelet agents. Its clinical usefulness in the prevention and treatment of cardiovascular disease (CVD) has been established by several large...
No takes yet. Share an insight, caveat, or question.
Tsoumani et al. (2015) studied this question. Generic clopidogrel formulations require bioequivalence evaluation to ensure their established clinical usefulness in treating cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: